San Antonio Breast Cancer Symposium

The latest news from SABCS, including researcher interviews and physician perspective.


Meeting NewsPerspective

Oral paclitaxel regimen improves outcomes vs. IV formulation in metastatic breast cancer

December 20, 2019
SAN ANTONIO — A novel combination of oral paclitaxel plus encequidar significantly improved overall response rates compared with IV paclitaxel…
Meeting NewsPerspective

Circulating tumor DNA predicts recurrence in early-stage triple-negative breast cancer

December 19, 2019
SAN ANTONIO — Detection of circulating tumor DNA after neoadjuvant chemotherapy appeared to independently predict disease recurrence among…
Meeting NewsPerspective

Anastrozole provides long-term preventive effect for postmenopausal women at high risk for breast cancer

December 16, 2019
SAN ANTONIO — Anastrozole reduced breast cancer risk by 49% compared with placebo for postmenopausal women at high risk for the disease…
Meeting NewsPerspective

Residual cancer burden predicts long-term outcomes across breast cancer subtypes

December 13, 2019
SAN ANTONIO — Residual cancer burden after neoadjuvant chemotherapy accurately predicted long-term recurrence risk and survival across all…
Meeting NewsPerspective

Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence

December 13, 2019
SAN ANTONIO — Two common hormone therapy regimens had opposite long-term effects on breast cancer incidence among postmenopausal women…
Meeting NewsPerspective

Accelerated partial breast irradiation effectively prevents recurrence in early breast cancer

December 13, 2019
SAN ANTONIO — Accelerated partial breast irradiation after surgery appeared as effective as whole breast irradiation for preventing recurrence…
Meeting News

Adjuvant chemotherapy offers limited benefit for invasive lobular carcinoma

December 13, 2019
SAN ANTONIO — Adjuvant chemoendocrine therapy did not extend survival compared with endocrine monotherapy for patients with invasive lobular…
Meeting News

Extended adjuvant letrozole improves DFS among certain postmenopausal women with breast cancer

December 13, 2019
SAN ANTONIO — Extended adjuvant endocrine therapy with letrozole improved DFS compared with placebo among postmenopausal women with hormone…
Meeting NewsPerspective

Atezolizumab fails to improve response in triple-negative breast cancer

December 12, 2019
SAN ANTONIO — The addition of atezolizumab to neoadjuvant chemotherapy failed to improve pathologic complete response rate for patients with…
Meeting NewsPerspective

Ado-trastuzumab emtansine extends DFS in early-stage HER2-positive breast cancer

December 12, 2019
SAN ANTONIO — Ado-trastuzumab emtansine extended DFS compared with paclitaxel plus trastuzumab among patients with early-stage HER2-positive…

Meeting Calendar

San Antonio Breast Cancer Symposium

December 4, 2018 - December 8, 2018